社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
ADiTx Therapeutics(ADTX)
0.0203
-0.0086
-29.76%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
Ignite Proteomics宣布启动万人前瞻性肿瘤登记研究，评估功能性蛋白质组学在癌症疗法选择中的应用
美股速递 · 06-08 20:16
Ignite Proteomics宣布启动万人前瞻性肿瘤登记研究，评估功能性蛋白质组学在癌症疗法选择中的应用
Aditxt任命Jeffrey M. Busch为临时首席执行官，其曾为股东创造约8.5%股息回报的10亿美元级纽交所企业创始人兼前CEO
美股速递 · 06-01
Aditxt任命Jeffrey M. Busch为临时首席执行官，其曾为股东创造约8.5%股息回报的10亿美元级纽交所企业创始人兼前CEO
ADiTx Therapeutics宣布1股并27股的反向拆股，将于2026年5月18日开盘时生效
美股速递 · 05-14
ADiTx Therapeutics宣布1股并27股的反向拆股，将于2026年5月18日开盘时生效
ADiTx Therapeutics收购Ignite Proteomics，破解癌症治疗关键难题：优化疗法选择
美股速递 · 03-13
ADiTx Therapeutics收购Ignite Proteomics，破解癌症治疗关键难题：优化疗法选择
ADiTx Therapeutics (纳斯达克: ADTX) 宣布1比8合股 将于2026年3月9日开盘时生效
美股速递 · 03-05
ADiTx Therapeutics (纳斯达克: ADTX) 宣布1比8合股 将于2026年3月9日开盘时生效
公司概况
公司名称
ADiTx Therapeutics
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.aditxt.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Aditxt, Inc.于2017年9月28日根据特拉华州法律注册成立。其使命是通过将高度集中的行业转型为社会所有和引导的生态系统，重新定义健康创新发现、开发和应用的方式，从而提升人类福祉。公司最初专注于一种名为ADI/Adimune的免疫调节技术，旨在延长器官移植患者的生命并提高其生活质量。此后，公司不断拓展其创新产品组合和子公司，同时持续评估各种有前景的健康创新技术。
06-09 12:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
06-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
06-01
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-29
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-21
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-15
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-08
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-01
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
04-18
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
04-14
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
04-07
重要事件披露
Form 8-K/A - Current report: [Amend]
Form 8-K/A - Current report: [Amend]
04-02
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
04-01
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03-30
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
03-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
分时
5日
日
周
月
数据加载中...
最高
0.0227
今开
0.0218
量比
4.42
最低
0.0195
昨收
0.0289
换手率
12612.21%
热议股票
{"pagemeta":{"title":"ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADiTx Therapeutics(ADTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADiTx Therapeutics,ADTX,ADiTx Therapeutics股票,ADiTx Therapeutics股票老虎,ADiTx Therapeutics股票老虎国际,ADiTx Therapeutics行情,ADiTx Therapeutics股票行情,ADiTx Therapeutics股价,ADiTx Therapeutics股市,ADiTx Therapeutics股票价格,ADiTx Therapeutics股票交易,ADiTx Therapeutics股票购买,ADiTx Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADiTx Therapeutics(ADTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"news","symbol":"ADTX","data":{"stockData":{"symbol":"ADTX","market":"US","secType":"STK","nameCN":"ADiTx Therapeutics","latestPrice":0.0203,"timestamp":1781103275068,"preClose":0.0289,"halted":0,"volume":102814772,"delay":0,"changeRate":-0.2975778546712803,"floatShares":815200,"shares":815900,"eps":-1380.7628,"marketStatus":"交易中","change":-0.0086,"latestTime":"06-10 10:54:36 EDT","open":0.0218,"high":0.0227,"low":0.0195,"amount":2089283.868040516,"amplitude":0.110727,"askPrice":0.021,"askSize":3900,"bidPrice":0.02,"bidSize":25,"shortable":0,"etf":0,"ttmEps":-1380.7628,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781121600000},"marketStatusCode":2,"adr":0,"listingDate":1593489600000,"exchange":"NASDAQ","adjPreClose":0.0289,"preHourTrading":{"tag":"盘前","latestPrice":0.0214,"preClose":0.0289,"latestTime":"09:29 EDT","volume":27672857,"amount":654859.813800809,"timestamp":1781098199999,"change":-0.0075,"changeRate":-0.259516,"amplitude":0.553633},"postHourTrading":{"tag":"盘后","latestPrice":0.029,"preClose":0.0289,"latestTime":"19:59 EDT","volume":24291469,"amount":716602.823637,"timestamp":1781049594295,"change":0.0001,"changeRate":0.00346,"amplitude":0.366782},"volumeRatio":4.417126,"impliedVol":6.3423,"impliedVolPercentile":0},"tweetData":null,"newsData":{"listData":[{"id":"1131244796","title":"Ignite Proteomics宣布启动万人前瞻性肿瘤登记研究，评估功能性蛋白质组学在癌症疗法选择中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1131244796","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131244796?lang=zh_cn&edition=full","pubTime":"2026-06-08 20:16","pubTimestamp":1780920977,"startTime":"0","endTime":"0","summary":"Ignite Proteomics公布了一项前瞻性肿瘤登记研究计划，拟纳入10,000名患者，旨在评估功能性蛋白质组学在癌症治疗方案选择中的实际应用价值。该大规模注册研究将系统性地收集真实世界数据，以深入分析基于蛋白质功能特征的检测方法如何优化临床治疗决策，并探索其在提升患者疗效与生存结局方面的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190255329","title":"Aditxt任命Jeffrey M. Busch为临时首席执行官，其曾为股东创造约8.5%股息回报的10亿美元级纽交所企业创始人兼前CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1190255329","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190255329?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:17","pubTimestamp":1780316235,"startTime":"0","endTime":"0","summary":"Aditxt, Inc. 已任命杰弗里·M·布施为临时首席执行官。布施先生是一位经验丰富的企业领导者，他曾创立并领导一家在纽约证券交易所上市、市值达10亿美元的企业，并为股东带来了约8.5%的股息回报。这一任命标志着公司领导层进入新的过渡阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165402862","title":"ADiTx Therapeutics宣布1股并27股的反向拆股，将于2026年5月18日开盘时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1165402862","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165402862?lang=zh_cn&edition=full","pubTime":"2026-05-14 20:15","pubTimestamp":1778760920,"startTime":"0","endTime":"0","summary":"ADiTx Therapeutics（纳斯达克股票代码：ADTX）宣布，其1股合并为27股的反向股票拆分计划，将于2026年5月18日市场开盘交易时正式生效。\n此项举措将显著提升公司每股股票的交易价格。反向拆股完成后，公司已发行普通股的数量将按比例大幅减少，而股东所持股票的总价值在理论上将保持不变。公司此举通常旨在满足交易所的最低股价要求，或提升其在投资者眼中的形象。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189339932","title":"ADiTx Therapeutics收购Ignite Proteomics，破解癌症治疗关键难题：优化疗法选择","url":"https://stock-news.laohu8.com/highlight/detail?id=1189339932","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189339932?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:19","pubTimestamp":1773404375,"startTime":"0","endTime":"0","summary":"ADiTx Therapeutics宣布完成对Ignite Proteomics的战略收购，旨在攻克癌症临床治疗中的核心瓶颈——个体化疗法优选难题。此次并购将通过整合双方在生物标志物检测与蛋白质组学分析领域的技术优势，为肿瘤患者提供更精准的治疗方案决策支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118817402","title":"ADiTx Therapeutics (纳斯达克: ADTX) 宣布1比8合股 将于2026年3月9日开盘时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1118817402","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118817402?lang=zh_cn&edition=full","pubTime":"2026-03-05 21:33","pubTimestamp":1772717585,"startTime":"0","endTime":"0","summary":"ADiTx Therapeutics (纳斯达克: ADTX) 公布，其1比8的反向股票分割计划已确定于2026年3月9日交易日开盘时正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADTX"],"isVideo":false,"video":null,"gpt_icon":0}],"currentPage":1,"bottom":true},"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"21374988","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026066823-ADTX","pdf_url":"","pub_time":1780977600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026066823/0001213900-26-066823-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM OF NOTE PURCHASE AGREEMENT, DATED AS OF JUNE 3, 2026, BY AND AMONG THE COMP","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026066823/ea029381201ex10-1.htm","primary":true,"translateUrl":"","linkName":"ea029381201ex10-1.htm","type":"EX-10.1","id":"NTFILEBm1BtgFSX2wzCWjN","market":"us","size":318084},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026066823/ea0293812-8k_aditxt.htm","primary":false,"translateUrl":"","linkName":"ea0293812-8k_aditxt.htm","type":"8-K","id":"NTFILECD4w4H2rBZFYDmQ4","market":"us","size":37381},{"description":"FORM OF SENIOR SECURED PROMISSORY NOTE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026066823/ea029381201ex10-2.htm","primary":false,"translateUrl":"","linkName":"ea029381201ex10-2.htm","type":"EX-10.2","id":"NTFILE4i76gzYdutV1BKaa","market":"us","size":94103},{"description":"FORM OF SECURITY AGREEMENT, DATED AS OF JUNE 3, 2026, BY AND BETWEEN IGNITE AND","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026066823/ea029381201ex10-3.htm","primary":false,"translateUrl":"","linkName":"ea029381201ex10-3.htm","type":"EX-10.3","id":"NTFILE3cCxC6tQtod1rce4","market":"us","size":275814},{"description":"FORM OF PLEDGE AGREEMENT, DATED AS OF JUNE 3, 2026, BY AND BETWEEN THE COMPANY A","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026066823/ea029381201ex10-4.htm","primary":false,"translateUrl":"","linkName":"ea029381201ex10-4.htm","type":"EX-10.4","id":"NTFILE3hTcxuEdeHNkfLKF","market":"us","size":109380}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-06-09 12:00","pubTimestamp":1780977600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21364612","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026065847-ADTX","pdf_url":"","pub_time":1780632000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026065847/0001213900-26-065847-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026065847/ea0293649-8k_aditxt.htm","primary":true,"translateUrl":"","linkName":"ea0293649-8k_aditxt.htm","type":"8-K","id":"NTFILE8Haf7poYVYuefqQV","market":"us","size":26806}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-06-05 12:00","pubTimestamp":1780632000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21336693","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026063165-ADTX","pdf_url":"","pub_time":1780286400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026063165/0001213900-26-063165-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE OF ADITXT, INC., DATED JUNE 1, 2026","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026063165/ea029290201ex99-1.htm","primary":true,"translateUrl":"","linkName":"ea029290201ex99-1.htm","type":"EX-99.1","id":"NTFILE5H8xk4Lr3BEuX377","market":"us","size":28146},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026063165/ea0292902-8k_aditxt.htm","primary":false,"translateUrl":"","linkName":"ea0292902-8k_aditxt.htm","type":"8-K","id":"NTFILEFYzf5XuHTTLCGfc5","market":"us","size":32184}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-06-01 12:00","pubTimestamp":1780286400,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21330570","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026062844-ADTX","pdf_url":"","pub_time":1780027200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/0001213900-26-062844-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/ea0292786-8k_aditxt.htm","primary":true,"translateUrl":"","linkName":"ea0292786-8k_aditxt.htm","type":"8-K","id":"NTFILE49BmzWJq7wu6a4XF","market":"us","size":32461}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-29 12:00","pubTimestamp":1780027200,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21291773","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026059562-ADTX","pdf_url":"","pub_time":1779309069000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ADTX","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1726711/0001213900-26-059562-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026059562/ea0290247-10q_aditxt.htm","primary":true,"translateUrl":"","linkName":"ea0290247-10q_aditxt.htm","type":"10-Q","id":"NTFILEAe7MrY1HvBAiaTRv","market":"us","size":1116893},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026059562/ea029024701ex31-1.htm","primary":false,"translateUrl":"","linkName":"ea029024701ex31-1.htm","type":"EX-31.1","id":"NTFILE6wuYGdea9se3P2rV","market":"us","size":11614},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026059562/ea029024701ex31-2.htm","primary":false,"translateUrl":"","linkName":"ea029024701ex31-2.htm","type":"EX-31.2","id":"NTFILEPMBkK1SvebUKVEQF","market":"us","size":11417},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026059562/ea029024701ex32-1.htm","primary":false,"translateUrl":"","linkName":"ea029024701ex32-1.htm","type":"EX-32.1","id":"NTFILE73BzrJEkdzNq5boQ","market":"us","size":5154}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-05-21 04:31","pubTimestamp":1779309069,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21269963","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026057811-ADTX","pdf_url":"","pub_time":1778817600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026057811/0001213900-26-057811-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.03: Material Modifications to Rights of Security Holders;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ADITXT, INC","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026057811/ea029070701ex3-1.htm","primary":true,"translateUrl":"","linkName":"ea029070701ex3-1.htm","type":"EX-3.1","id":"NTFILECReD7Eburg7J1qZi","market":"us","size":6161},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026057811/ea0290707-8k_aditxt.htm","primary":false,"translateUrl":"","linkName":"ea0290707-8k_aditxt.htm","type":"8-K","id":"NTFILE6vtwxcvGDNip2nRs","market":"us","size":28731},{"description":"PRESS RELEASE DATED MAY 14, 2026","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026057811/ea029070701ex99-1.htm","primary":false,"translateUrl":"","linkName":"ea029070701ex99-1.htm","type":"EX-99.1","id":"NTFILE8FuGB6WHzJyH2jFA","market":"us","size":7048}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-15 12:00","pubTimestamp":1778817600,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21234288","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026053904-ADTX","pdf_url":"","pub_time":1778212800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026053904/0001213900-26-053904-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026053904/ea0289662-8k_aditxt.htm","primary":true,"translateUrl":"","linkName":"ea0289662-8k_aditxt.htm","type":"8-K","id":"NTFILEDpAsSEEZfo4VxK9C","market":"us","size":27382}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-08 12:00","pubTimestamp":1778212800,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21202242","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026050995-ADTX","pdf_url":"","pub_time":1777608000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026050995/0001213900-26-050995-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026050995/ea0288779-8k_aditxt.htm","primary":true,"translateUrl":"","linkName":"ea0288779-8k_aditxt.htm","type":"8-K","id":"NTFILEC8P9wkKr1TKYzB5G","market":"us","size":36738}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-01 12:00","pubTimestamp":1777608000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21285496","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026045143-ADTX","pdf_url":"","pub_time":1776456002000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ADTX","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/0001213900-26-045143-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026045143/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE7fy55112nM3fvgu7","market":"us","size":5070}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-04-18 04:00","pubTimestamp":1776456002,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20999058","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026043227-ADTX","pdf_url":"","pub_time":1776139200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026043227/0001213900-26-043227-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM OF NOTE (APRIL 2026)","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026043227/ea028616801ex10-1.htm","primary":true,"translateUrl":"","linkName":"ea028616801ex10-1.htm","type":"EX-10.1","id":"NTFILE8riuN7kTdBtQuJEh","market":"us","size":170021},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026043227/ea0286168-8k_aditxt.htm","primary":false,"translateUrl":"","linkName":"ea0286168-8k_aditxt.htm","type":"8-K","id":"NTFILE33CjUEFTEy6eX7yy","market":"us","size":39181}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-04-14 12:00","pubTimestamp":1776139200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第2.03项：直接财务义务或注册人资产负债表外安排下的义务的产生；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20967926","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026041018-ADTX","pdf_url":"","pub_time":1775534400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"ADTX","title":"Form 8-K/A - Current report: [Amend]","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/0001213900-26-041018-index.htm","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/ea0285319-8ka1_aditxt.htm","primary":true,"translateUrl":"","linkName":"ea0285319-8ka1_aditxt.htm","type":"8-K/A","id":"NTFILEDZaDuY9Jz68spDZR","market":"us","size":31005},{"description":"CONSENT OF CBIZ CPAS P.C","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/ea028531901ex23-1.htm","primary":false,"translateUrl":"","linkName":"ea028531901ex23-1.htm","type":"EX-23.1","id":"NTFILEBsyxJDeXbsXrPfor","market":"us","size":2406},{"description":"AUDITED FINANCIAL STATEMENTS OF IGNITE PROTEOMICS LLC AS OF DECEMBER 31, 2025 AN","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/ea028531901ex99-1.htm","primary":false,"translateUrl":"","linkName":"ea028531901ex99-1.htm","type":"EX-99.1","id":"NTFILE6d6GUd1zeXacPeWA","market":"us","size":141047},{"description":"UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION AS OF AND FOR THE YEAR EN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/ea028531901ex99-2.htm","primary":false,"translateUrl":"","linkName":"ea028531901ex99-2.htm","type":"EX-99.2","id":"NTFILEGQcifh4ZpmLNhsEv","market":"us","size":160834},{"description":"UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION AS OF AND FOR THE YEAR EN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/ea028531901ex99-3.htm","primary":false,"translateUrl":"","linkName":"ea028531901ex99-3.htm","type":"EX-99.3","id":"NTFILEAqorh4nj6AoPH1Cc","market":"us","size":167957},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/ea028531901_ex23-1img1.jpg","primary":false,"translateUrl":"","linkName":"ea028531901_ex23-1img1.jpg","type":"GRAPHIC","id":"NTFILE5KpeFay6NUXtL82x","market":"us","size":15198},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/ea028531901_ex23-1img2.jpg","primary":false,"translateUrl":"","linkName":"ea028531901_ex23-1img2.jpg","type":"GRAPHIC","id":"NTFILEAmT3vPoCvGxD61mQ","market":"us","size":13795},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026041018/ea028531901_ex99-1img1.jpg","primary":false,"translateUrl":"","linkName":"ea028531901_ex99-1img1.jpg","type":"GRAPHIC","id":"NTFILE7myJ6yw39jaFJbvD","market":"us","size":12686}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-04-07 12:00","pubTimestamp":1775534400,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20953035","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026038906-ADTX","pdf_url":"","pub_time":1775102400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026038906/0001213900-26-038906-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026038906/ea0284653-8k_aditxt.htm","primary":true,"translateUrl":"","linkName":"ea0284653-8k_aditxt.htm","type":"8-K","id":"NTFILEELLqL6dP1ctPcCWU","market":"us","size":23995}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-04-02 12:00","pubTimestamp":1775102400,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events","summary_zh":"项目8.01：其他事项","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20939813","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026037529-ADTX","pdf_url":"","pub_time":1774989306000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"ADTX","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1726711/0001213900-26-037529-index.html","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea0283141-10k_aditxt.htm","primary":true,"translateUrl":"","linkName":"ea0283141-10k_aditxt.htm","type":"10-K","id":"NTFILE9CNfq6N2qV3RPKhT","market":"us","size":2600442},{"description":"AMENDMENT NO. 6 TO AMENDED AND RESTATED MERGER AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea028314101ex10-211.htm","primary":false,"translateUrl":"","linkName":"ea028314101ex10-211.htm","type":"EX-10.211","id":"NTFILEBs1WiwKYENi5neQm","market":"us","size":18883},{"description":"OFFICER LETTER WITH CHRISTOPHER . PORCELLI DATED SEPTEMBER 30, 2025","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea028314101ex10-212.htm","primary":false,"translateUrl":"","linkName":"ea028314101ex10-212.htm","type":"EX-10.212","id":"NTFILEH3Up4xuywyJ8AUD4","market":"us","size":29873},{"description":"CONSENT OF DBBMCKENNON, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea028314101ex23-1.htm","primary":false,"translateUrl":"","linkName":"ea028314101ex23-1.htm","type":"EX-23.1","id":"NTFILE31K1Jf9SMQ5Hy52J","market":"us","size":1828},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea028314101ex31-1.htm","primary":false,"translateUrl":"","linkName":"ea028314101ex31-1.htm","type":"EX-31.1","id":"NTFILE5LYycrMcN3BEjyJK","market":"us","size":11175},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea028314101ex31-2.htm","primary":false,"translateUrl":"","linkName":"ea028314101ex31-2.htm","type":"EX-31.2","id":"NTFILE2Vn5QAzL6xBLrbnC","market":"us","size":10979},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea028314101ex32-1.htm","primary":false,"translateUrl":"","linkName":"ea028314101ex32-1.htm","type":"EX-32.1","id":"NTFILE7NfUkAPG7pbx6Et5","market":"us","size":5143},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea028314101_ex10-212img1.jpg","primary":false,"translateUrl":"","linkName":"ea028314101_ex10-212img1.jpg","type":"GRAPHIC","id":"NTFILECLKNL8GtpegUVEFt","market":"us","size":3798},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026037529/ea028314101_ex10-212img2.jpg","primary":false,"translateUrl":"","linkName":"ea028314101_ex10-212img2.jpg","type":"GRAPHIC","id":"NTFILE97QZ2hy16NJZ2PLB","market":"us","size":63888}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2026-04-01 04:35","pubTimestamp":1774989306,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20921185","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026035973-ADTX","pdf_url":"","pub_time":1774843200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026035973/0001213900-26-035973-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON, LLP","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026035973/ea028397901_ex5-1.htm","primary":true,"translateUrl":"","linkName":"ea028397901_ex5-1.htm","type":"EX-5.1","id":"NTFILEFQ4CSzNtUFVipmop","market":"us","size":14393},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026035973/ea0283979-8k_aditxt.htm","primary":false,"translateUrl":"","linkName":"ea0283979-8k_aditxt.htm","type":"8-K","id":"NTFILEGe5vjqP8xmJAeRhc","market":"us","size":26844},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026035973/ea028397901_ex5-1img1.jpg","primary":false,"translateUrl":"","linkName":"ea028397901_ex5-1img1.jpg","type":"GRAPHIC","id":"NTFILECjDQvkTypEajegY6","market":"us","size":3427}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-30 12:00","pubTimestamp":1774843200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20830417","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026027281-ADTX","pdf_url":"","pub_time":1773374400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ADTX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/0001213900-26-027281-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CERTIFICATE OF DESIGNATIONS OF RIGHTS AND PREFERENCES OF SERIES A-2 CONVERTIBLE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/ea027944301ex3-1.htm","primary":true,"translateUrl":"","linkName":"ea027944301ex3-1.htm","type":"EX-3.1","id":"NTFILE7ghh6antixgNJEMH","market":"us","size":177366},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/ea0279443-8k_aditxt.htm","primary":false,"translateUrl":"","linkName":"ea0279443-8k_aditxt.htm","type":"8-K","id":"NTFILE5zRaupoPU6bo6hc2","market":"us","size":58722},{"description":"SECURITIES PURCHASE AGREEMENT DATED AS OF MARCH 11, 2026 BY AND BETWEEN THE COMP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/ea027944301ex10-1.htm","primary":false,"translateUrl":"","linkName":"ea027944301ex10-1.htm","type":"EX-10.1","id":"NTFILEGJuMZ6SXRJD2cVjR","market":"us","size":321474},{"description":"NOTE PURCHASE AGREEMENT DATED AS OF MARCH 11, 2026 BY AND BETWEEN THE COMPANY AN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/ea027944301ex10-2.htm","primary":false,"translateUrl":"","linkName":"ea027944301ex10-2.htm","type":"EX-10.2","id":"NTFILEBsB6p4c4mj62tgcp","market":"us","size":70389},{"description":"PRESS RELEASE DATED MARCH 13, 2026","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/ea027944301ex99-1.htm","primary":false,"translateUrl":"","linkName":"ea027944301ex99-1.htm","type":"EX-99.1","id":"NTFILE5zJpw4wNLVnYNaUR","market":"us","size":15146}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-13 12:00","pubTimestamp":1773374400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第2.01项：资产收购或处置完成；第2.03项：设立直接财务义务或注册人资产负债表外安排下的义务；第3.02项：未经登记的股本证券销售；第5.03项：公司章程或章程的修订；财政年度的变化；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.aditxt.com","stockEarnings":[{"period":"1week","weight":-0.7368},{"period":"1month","weight":-0.991},{"period":"3month","weight":-0.9996},{"period":"6month","weight":-0.9999},{"period":"1year","weight":-1},{"period":"ytd","weight":-0.9998}],"compareEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.0898},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.2291},{"period":"ytd","weight":0.0808}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aditxt, Inc.于2017年9月28日根据特拉华州法律注册成立。其使命是通过将高度集中的行业转型为社会所有和引导的生态系统，重新定义健康创新发现、开发和应用的方式，从而提升人类福祉。公司最初专注于一种名为ADI/Adimune的免疫调节技术，旨在延长器官移植患者的生命并提高其生活质量。此后，公司不断拓展其创新产品组合和子公司，同时持续评估各种有前景的健康创新技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.013912},{"month":2,"riseRate":0,"avgChangeRate":-0.246425},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.263289},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.355403},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.26782},{"month":6,"riseRate":0,"avgChangeRate":-0.33485},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.120854},{"month":8,"riseRate":0.166667,"avgChangeRate":0.274702},{"month":9,"riseRate":0,"avgChangeRate":-0.488285},{"month":10,"riseRate":0,"avgChangeRate":-0.418091},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.288889},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.245759}],"exchange":"NASDAQ","name":"ADiTx Therapeutics","nameEN":"ADiTx Therapeutics"},"aProfile":null}}}